期刊文献+

血清尿酸水平与非酒精性脂肪肝发病的相关性研究 被引量:8

Study of correlation between serum uric acid level and prevalence of nonalcoholic fatty liver
下载PDF
导出
摘要 目的研究血清尿酸(SUA)水平与非酒精性脂肪肝(NAFL)发病的关系。方法选入246例NAFL患者为NAFL组和年龄匹配的门诊健康体检排除脂肪肝者246例为无NAFL组,比较两组SUA水平;将入选者SUA水平四分位处理,分析各段SUA水平和NAFL发病率的关系;用Logistic回归分析NAFL的危险因素。结果 NAFL组SUA水平增高(P〈0.01),且随尿酸水平增高,受试者的NAFL患病率也成倍增长(Q1~Q4依次为11.91%、27.74%、47.67%、85.04%),Logistic回归分析证明高尿酸血症是NAFL的独立危险因素(OR:1.579;95%C I:1.080~1.628,P〈0.01)。结论高SUA水平与NAFL发病关系密切,SUA可能是NAFL发病机制研究和临床防治新的靶点。 Objective To investigate the correlation between serum uric acid(SUA)level and the prevalence of nonalcoholic fatty liver.Methods 246 patients with nonalcoholic fatty liver(NAFL)were selected as NAFL group,while 246 controls ruled out NAFL by health examination in our outpatient department were selected as non-NAFL group.The blood samples of all subjects were collected for the comparison of SUA level between the two groups.In addition,their SUA levels were divided into four ranges(Q1:male ≤ 334 μmol/L,female ≤ 272 μmol/L;Q2:male 335-381 μmol/L,female 273-311 μmol/L;Q3:male 382-425 μmol/L,female 312-356 μmol/L;Q4:male ≥ 426 μmol/L,female ≥357 μmol/L),and the correlation between each range of SUV level and the prevalence of NAFL were analyzed.Meanwhile,logistic regression analysis was applied to study the risk factors of NAFL.Results SUA level in NAFL group was significantly higher than that in non-NAFL group(P0.01).The prevalence of NAFL almost doubled with the increase of SUA level.From Q1 to Q4,it was 11.91%,27.74%,47.67% and 85.04% in turn.Logistic regression analysis showed that hyperuricemia was an independent risk factor of NAFL(OR:1.579;95% CI:1.080-1.628,P0.01).Conclusion High SUA level appears to be significantly associated with the onset of NAFL,and SUA may be a novel target for the researches on the pathogenesis,prevention and treatment of this disease.
出处 《西南国防医药》 CAS 2010年第12期1295-1297,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 尿酸 非酒精性脂肪肝 相关性 serum uric acid nonalcoholic fatty liver correlation
  • 相关文献

参考文献11

  • 1Jimba S,Nakagami T,Takahashi M,et al.Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults[J].Diabet Med,2005,22:1141-1145. 被引量:1
  • 2Marchesini G,Bugianesi E,Forlani G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome[J].Hepatology,2003,37:917-923. 被引量:1
  • 3Choi H K,Ford E S.Prevalence of the metabolic syndrome in individuals with hyperuricemia[J].Am J Med,2007,120:442-447. 被引量:1
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 5Fang J,Alderman M H.Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study,1971-1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283:2404-2410. 被引量:1
  • 6Matsubara M,Chiba H,Maruoka S,et al.Elevated serum leptin concentrations in women with hyperuricemia[J].J Atheroscler Thromb,2002,9:28-34. 被引量:1
  • 7Cappuccio F P,Strazzullo P,Farinaro E,et al.Uric acid metabolism and tubular sodium handling.Results from a population-based study[J].JAMA,1993,270:354-359. 被引量:1
  • 8Garcia-Ruiz I,Rodriguez-Juan C,Diaz-Sanjuan T,et al.Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice[J].Hepatology,2006,44:581-591. 被引量:1
  • 9Hayden M R,Tyagi S C.Uric acid:a new look at an old risk marker for cardiovascular disease,metabolic syndrome,and type 2 diabetes mellitus:The urate redox shuttle[J].Nutr Metab(Lond),2004,1:10. 被引量:1
  • 10Sookoian S,Pirola C J.Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis:a systematic review[J].J Hepatol,2008,49:600-607. 被引量:1

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649. 被引量:1
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219. 被引量:1
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231. 被引量:1
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397. 被引量:1
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490. 被引量:1
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44. 被引量:1
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261. 被引量:1
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215. 被引量:1
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861. 被引量:1

共引文献1511

同被引文献132

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部